Evidence map›Paper›PMID 26343719›Full record

ArticleNutrients2015

The Effect of Changing Serum 25-Hydroxyvitamin D Concentrations on Metabolic Syndrome: A Longitudinal Analysis of Participants of a Preventive Health Program.

Truong-Minh Pham, John Paul Ekwaru, Solmaz Setayeshgar, Paul J Veugelers

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Vitamin DImmunity, inflammation and disease · 2017
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Truong-Minh PhamPopulation Health Intervention Research Unit, School of Public Health, University of Alberta 3-50 University Terrace, 8303-112 street NW, Edmonton, AB T6G 2T4, Canada. TruongMinh.Pham@ualberta.ca.
John Paul EkwaruPopulation Health Intervention Research Unit, School of Public Health, University of Alberta 3-50 University Terrace, 8303-112 street NW, Edmonton, AB T6G 2T4, Canada. ekwaru@ualberta.ca.
Solmaz SetayeshgarPopulation Health Intervention Research Unit, School of Public Health, University of Alberta 3-50 University Terrace, 8303-112 street NW, Edmonton, AB T6G 2T4, Canada. zohreh@ualberta.ca.
Paul J VeugelersPopulation Health Intervention Research Unit, School of Public Health, University of Alberta 3-50 University Terrace, 8303-112 street NW, Edmonton, AB T6G 2T4, Canada. Paul.Veugelers@ualberta.ca.
University of Alberta · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Several studies have shown that a poor vitamin D status may increase the risk of developing metabolic syndrome, which leaves the question whether improving one's vitamin D status may reduce the risk for the syndrome. Here we investigate the effect of temporal changes in serum 25-hydroxyvitamin D (25(OH)D) concentrations on metabolic syndrome among Canadians enrolled in a preventive health program that promotes vitamin D supplementation. We accessed and analyzed data of 6682 volunteer participants with repeated observations on serum 25(OH)D concentrations and metabolic syndrome. We applied logistic regression to quantify the independent contribution of baseline serum 25(OH)D and temporal increases in serum 25(OH)D to the development of metabolic syndrome. In the first year in the program, participants, on average, increased their serum 25(OH)D concentrations by 37 nmol/L. We observed a statistical significant inverse relationship of increases in serum 25(OH)D with risk for metabolic syndrome. Relative to those without improvements, those who improved their serum 25(OH)D concentrations with less 25 nmol/L, 25 to 50 nmol/L, 50 to 75 nmol/L, and more 75 nmol/L had respectively 0.76, 0.64, 0.59, 0.56 times the risk for metabolic syndrome at follow up. These estimates were independent of the effect of baseline serum 25(OH)D concentrations on metabolic syndrome. Improvement of vitamin D status may help reduce the public health burden of metabolic syndrome, and potential subsequent health conditions including type 2 diabetes and cardiovascular disease.

Indexed as

Dietary SupplementsAdultAgedAlbertaBiomarkersFemaleHealth StatusHumansLongitudinal StudiesMaleMetabolic SyndromeMiddle AgedPrevalencePrimary PreventionProgram EvaluationSeasons25-hydroxyvitamin DBiomarkersVitamin Dlongitudinal studymetabolic syndromeserum 25(OH)Dvitamin Dvitamin D supplementation

Identifiers

PMID26343719
PMCPMC4586533
OpenAlexW2098256703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.